Search for Clinical Trial Results
Nephrotic Syndrome - 28 Studies Found
Status | Study |
Recruiting |
Study Name: Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome:a Prospective Observational Study Condition: Nephrotic Syndrome,Idiopathic Date: 2014-10-20 Interventions: Drug: prednisone Full-dose induction period: Prednisone 1mg/kg.day, maximum 60mg/day, orally, divided in |
Completed |
Study Name: Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR) Condition: Treatment Resistant Nephrotic Syndrome Date: 2010-05-21 Interventions: Drug: ACTHAR gel Patients will be treated with ACTHAR gel starting with 40 units given twice weekly subc |
Completed |
Study Name: Factors of Steroid Dependency in Idiopathic Nephrotic Syndrome Condition: Idiopathic Nephrotic Syndrome Date: 2012-04-25 Interventions: Genetic: DNA chip dedicated to the pharmacogenetic of steroids direct DNA extraction from peripheral blo |
Recruiting |
Study Name: Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2016-12-16 Interventions:
|
Recruiting |
Study Name: Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor Dependent Idiopathic Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2015-03-06 Interventions:
|
NOT_YET_RECRUITING |
Study Name: Effectiveness of Educational Gamified Cards About Nephrotic Syndrome Condition: Date: 2024-05-19 Interventions:
|
NOT_YET_RECRUITING |
Study Name: Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2024-05-19 Interventions: ADX-629 (250 milligrams) administered twice daily |
RECRUITING |
Study Name: A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome Condition: Childhood Idiopathic Nephrotic Syndrome Date: 2024-05-19 Interventions: Obinutuzumab will be administered as per schedule specified in the respective arm. |